Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  253.93
-0.07 (-0.03%)
AAPL  268.30
-0.75 (-0.28%)
AMD  255.22
-4.43 (-1.70%)
BAC  53.68
+0.12 (0.22%)
GOOG  280.64
-3.48 (-1.22%)
META  637.50
-0.21 (-0.03%)
MSFT  513.02
-4.00 (-0.77%)
NVDA  202.37
-4.51 (-2.18%)
ORCL  253.46
-4.39 (-1.70%)
TSLA  459.82
-8.55 (-1.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.